What are the recommended interventions to reduce airway mucus accumulation?

Reducing Airway Mucus Buildup

Start with chest physiotherapy combining postural drainage, percussion, and the forced expiratory technique (huffing), which should be taught to all patients as first-line therapy for mucus clearance. 1, 2

Primary Airway Clearance Techniques

Forced Expiratory Technique (Huffing)

• Huffing consists of one or two forced expirations without glottic closure, starting from mid-lung to low lung volume, followed by relaxed breathing. This generates lower intrapulmonary pressures than coughing, reducing airway collapse while maintaining effective secretion clearance. 1
• Huffing is as effective as directed cough for moving secretions proximally in COPD patients and should be taught as an adjunct to other clearance methods. 1
• In cystic fibrosis, huffing combined with postural drainage or positive expiratory pressure (PEP) improves sputum clearance compared to no treatment. 1

Autogenic Drainage

• This self-administered technique uses controlled expiratory airflow during tidal breathing at three progressive lung volumes: "unsticking" mucus at low volumes, "collecting" at mid-volumes, and "evacuating" at high volumes, followed by huffing or coughing. 1
• Autogenic drainage clears mucus faster than postural drainage in cystic fibrosis patients and has the advantage of being performed independently in the seated position without assistance. 1

Positive Expiratory Pressure (PEP) Therapy

• PEP involves exhaling against 5–20 cm H₂O resistance for 20 minutes twice daily, combined with forced expiration and coughing. 3
• The American College of Chest Physicians recommends PEP over conventional chest physiotherapy in cystic fibrosis, citing comparable effectiveness, lower cost, and self-administration capability (Grade B). 3
• PEP increases pressure behind secretions via collateral ventilation and prevents airway collapse during expiration. 3
• Cochrane review of 20 studies found no significant differences between PEP and physiotherapy for short-term outcomes, but patients consistently preferred PEP in trials lasting ≥1 month. 3

Osmotic Agents for Mucus Hydration

Hypertonic Saline

• Nebulized hypertonic saline (7% concentration) increases mucus clearance acutely in a dose-dependent manner, with clearance rates of 23.8% over 90 minutes compared to 12.7% with normal saline. 4
• Randomized, double-blind, placebo-controlled trials demonstrate that hypertonic saline enhances cough clearance in patients with bronchitis. 2
• The mechanism involves drawing water osmotically into airway surfaces to rehydrate concentrated mucus. 5, 4

Inhaled Mannitol

• Mannitol dry powder (approximately 300 mg) produces marked acute effects, with 34% clearance over 75 minutes in bronchiectasis patients versus 17.4% with control. 4
• Mannitol reduces 24-hour retention of mucus, suggesting effects extend beyond the acute phase—helping patients clear in 2 hours what would otherwise take 24 hours. 4
• In cystic fibrosis, mannitol is equally effective as 6% hypertonic saline for improving ciliary and cough clearance (27.6% vs 31.0% total clearance over 120 minutes). 4

Device-Based Therapies

High-Frequency Chest Wall Oscillation (HFCWO)

• HFCWO vest therapy is most advantageous for patients producing >20–30 mL of mucus per day who cannot use PEP devices or receive manual chest physiotherapy. 3
• Protocol: Administer bronchodilator first, then perform two consecutive 20-minute HFCWO sessions, followed by patient-initiated cough or huff. 3
• Critical caveat: A 2018 CHEST analysis found HFCWO was associated with significantly higher risk of antibiotic-treated exacerbations compared with PEP (odds ratio 4.10,95% CI 1.42–11.84) in cystic fibrosis patients. 3
• The American College of Chest Physicians assigns HFCWO a Grade I recommendation (low evidence, conflicting benefit) as an alternative to conventional chest physiotherapy. 3

Oscillating PEP Devices

• Flutter devices and oscillating PEP devices (e.g., Aerobika) provide alternatives that combine PEP with oscillatory effects to enhance mucus mobilization. 3, 6

Mechanical Cough Assistance

Insufflator-Exsufflator Devices

• Mechanical insufflator-exsufflator devices generate higher peak cough flows than breath-stacking or manual assistance, making them valuable when peak cough flow is <270 L/min or maximal expiratory pressure is <60 cm H₂O. 2
• These devices are especially effective for patients with neuromuscular weakness or scoliosis that limits manual cough effectiveness. 2

Manually Assisted Cough

• In patients with expiratory muscle weakness, manually assisted cough should be considered to reduce respiratory complications (Grade C recommendation). 1
• Absolute contraindication: In COPD or airflow obstruction, manually assisted cough is detrimental—reducing peak expiratory flow by 144 L/min—and should not be used (Grade D recommendation). 1, 3

Bronchoscopic Intervention

• Flexible bronchoscopy is the definitive therapy for persistent mucus plugs causing atelectasis when all non-invasive methods have failed, allowing direct visualization and removal of obstructions. 2
• Most plugs can be cleared with flexible bronchoscopy; large resistant plugs may require rigid bronchoscopy. 2
• Proceed to bronchoscopy if no clinical improvement occurs within 12–24 hours of chest physiotherapy or if the patient deteriorates. 2

Mucoactive Pharmacologic Agents

Mucolytics

• Classic mucolytics with free thiol groups degrade mucin polymers in secretions. 7
• Peptide mucolytics (e.g., dornase alfa) break pathologic filaments of neutrophil-derived DNA and actin in purulent sputum. 7

Mucoregulatory Agents

• These reduce the volume of airway mucus secretion and are especially effective in hypersecretory states such as bronchorrhea and diffuse panbronchiolitis. 7
• Options include anti-inflammatory agents (glucocorticosteroids), anticholinergic agents, and macrolide antibiotics. 7

Critical Contraindications and Pitfalls

• Never use manually assisted cough or HFCWO in COPD patients—both worsen clinical outcomes and reduce peak expiratory flow. 1, 3
• Routine instillation of normal saline during suctioning is not recommended because it does not thin mucus, may lower oxygen saturation, and can contaminate lower airways. 2
• When suctioning is necessary, use the largest-diameter catheter that fits, perform rapid suctioning lasting <5 seconds, and maintain adequate humidification rather than instilling saline. 2
• Airway clearance techniques must be taught by healthcare professionals with advanced training to ensure proper technique and safety. 3

Clinical Algorithm

1. Initiate chest physiotherapy (postural drainage, percussion, huffing) immediately for acute mucus accumulation. 1, 2
2. Add nebulized hypertonic saline (7%) or inhaled mannitol to enhance mucus hydration and clearance. 2, 4
3. If peak cough flow is <270 L/min, add mechanical insufflator-exsufflator support. 2
4. For cystic fibrosis patients, prioritize PEP therapy over HFCWO due to better safety profile and patient preference. 3
5. If no improvement within 12–24 hours or clinical deterioration occurs, proceed to flexible bronchoscopy for direct mucus plug removal. 2